Total Payments
$55,786
2024 Payments
$6,007
Companies
79
Transactions
1,580
Medicare Patients
6,549
Medicare Billing
$2.9M
Payment Breakdown by Category
Food & Beverage$35,476 (63.6%)
Consulting$14,455 (25.9%)
Other$3,263 (5.8%)
Travel$1,341 (2.4%)
Education$1,251 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $35,476 | 1,536 | 63.6% |
| Consulting Fee | $14,455 | 6 | 25.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,263 | 3 | 5.8% |
| Travel and Lodging | $1,341 | 6 | 2.4% |
| Education | $1,251 | 29 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $7,789 | 125 | $0 (2024) |
| Eisai Inc. | $6,290 | 23 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $3,751 | 89 | $0 (2024) |
| Janssen Biotech, Inc. | $2,965 | 127 | $0 (2024) |
| Exelixis Inc. | $2,770 | 51 | $0 (2024) |
| TAIHO ONCOLOGY, INC. | $2,747 | 10 | $0 (2024) |
| ABBVIE INC. | $2,416 | 18 | $0 (2024) |
| Genentech USA, Inc. | $2,285 | 114 | $0 (2024) |
| Amgen Inc. | $2,068 | 74 | $0 (2023) |
| PFIZER INC. | $2,043 | 106 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,007 | 230 | Janssen Biotech, Inc. ($721.47) |
| 2023 | $8,685 | 250 | TAIHO ONCOLOGY, INC. ($2,624) |
| 2022 | $7,737 | 224 | ABBVIE INC. ($2,106) |
| 2021 | $9,653 | 187 | Eisai Inc. ($4,298) |
| 2020 | $6,019 | 131 | Eisai Inc. ($1,757) |
| 2019 | $4,862 | 226 | AstraZeneca Pharmaceuticals LP ($697.77) |
| 2018 | $3,037 | 133 | Genentech USA, Inc. ($319.85) |
| 2017 | $9,785 | 199 | Novartis Pharmaceuticals Corporation ($6,361) |
All Payment Transactions
1,580 individual payment records from CMS Open Payments — Page 1 of 64
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $34.29 | General |
| Category: Oncology | ||||||
| 12/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: BioOncology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $6.99 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Oncology | ||||||
| 12/09/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $32.97 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $40.04 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Oncology | ||||||
| 11/25/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: Oncology | ||||||
| 11/23/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.91 | General |
| 11/15/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $118.54 | General |
| 11/13/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Oncology | ||||||
| 11/11/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,133 | 19,231 | $1.0M | $395,822 |
| 2022 | 28 | 1,784 | 37,644 | $2.5M | $944,682 |
| 2021 | 29 | 2,049 | 87,355 | $1.4M | $821,405 |
| 2020 | 22 | 1,583 | 63,987 | $1.3M | $741,543 |
Total Patients
6,549
Total Services
208,217
Medicare Billing
$2.9M
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 18 | 9,660 | $431,687 | $177,077 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 359 | 1,026 | $278,180 | $96,895 | 34.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 41 | 328 | $98,187 | $39,495 | 40.2% |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 2023 | 50 | 214 | $29,960 | $19,972 | 66.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 210 | $40,547 | $13,437 | 33.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 134 | 228 | $43,926 | $10,480 | 23.9% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 36 | 223 | $14,506 | $5,827 | 40.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 38 | $14,790 | $5,512 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $13,011 | $4,561 | 35.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 364 | $11,097 | $4,442 | 40.0% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 13 | 70 | $10,125 | $4,129 | 40.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 60 | $9,153 | $3,837 | 41.9% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 110 | $7,668 | $3,355 | 43.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 19 | 97 | $5,933 | $2,444 | 41.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 27 | 128 | $4,358 | $1,784 | 40.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 26 | $3,839 | $1,437 | 37.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 20 | 55 | $696.42 | $421.68 | 60.5% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 36 | 4,008 | $931.24 | $283.25 | 30.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 31 | 2,046 | $563.09 | $194.28 | 34.5% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 37 | 236 | $501.74 | $185.80 | 37.0% |
| J3490 | Unclassified drugs | Office | 2023 | 14 | 68 | $1,072 | $53.14 | 5.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 11 | 5,780 | $797,774 | $315,354 | 39.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 22 | 8,100 | $349,632 | $139,100 | 39.8% |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | Office | 2022 | 12 | 4,100 | $374,989 | $136,385 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 360 | 1,053 | $300,080 | $108,731 | 36.2% |
About Dr. Honghao Yang, MD
Dr. Honghao Yang, MD is a Specialist healthcare provider based in Alhambra, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114946696.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Honghao Yang, MD has received a total of $55,786 in payments from pharmaceutical and medical device companies, with $6,007 received in 2024. These payments were reported across 1,580 transactions from 79 companies. The most common payment nature is "Food and Beverage" ($35,476).
As a Medicare-enrolled provider, Yang has provided services to 6,549 Medicare beneficiaries, totaling 208,217 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Alhambra, CA
- Active Since 07/18/2006
- Last Updated 04/28/2016
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114946696
Products in Payments
- Lenvima (Drug) $6,245
- PDR001 (Drug) $5,456
- INQOVI (Drug) $2,583
- Cabometyx (Drug) $2,213
- VENCLEXTA (Drug) $2,165
- DARZALEX (Biological) $1,135
- IMBRUVICA (Drug) $1,103
- OPDIVO (Biological) $892.58
- JAKAFI (Drug) $839.53
- VERZENIO (Drug) $828.67
- KEYTRUDA (Biological) $813.19
- IBRANCE (Drug) $781.78
- XTANDI (Drug) $772.39
- Trodelvy (Drug) $678.63
- Stivarga (Drug) $675.36
- TAGRISSO (Drug) $671.74
- KISQALI (Drug) $621.87
- LYNPARZA (Drug) $613.73
- VENCLEXTA (Biological) $599.53
- CABOMETYX (Drug) $557.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Alhambra
Lakhi Sakhrani, M.d, M.D
Specialist — Payments: $2,964
Specialist $2,964
Dr. Eddie Hu, M.d, M.D
Specialist — Payments: $2,066
Specialist $2,066
Dr. Thuc Bach, M.d, M.D
Specialist — Payments: $680.98
Specialist $680.98
Dr. Albert Mak, M.d, M.D
Specialist — Payments: $587.21
Specialist $587.21
Dr. San Nguyen, Md, MD
Specialist — Payments: $455.47
Specialist $455.47
Jeffrey Tsai, M.d, M.D
Specialist — Payments: $84.69
Specialist $84.69